These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33050202)

  • 1. The Crucial Role of Xanthine Oxidase in CKD Progression Associated with Hypercholesterolemia.
    Kim YJ; Oh SH; Ahn JS; Yook JM; Kim CD; Park SH; Cho JH; Kim YL
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute inhibition of the endogenous xanthine oxidase improves renal hemodynamics in hypercholesterolemic pigs.
    Daghini E; Chade AR; Krier JD; Versari D; Lerman A; Lerman LO
    Am J Physiol Regul Integr Comp Physiol; 2006 Mar; 290(3):R609-15. PubMed ID: 16284087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xanthine oxidase/NADPH oxidase inhibition by hydralazine attenuates acute kidney injury and prevents the transition of acute kidney injury to chronic kidney disease.
    Chiang CH; Chen C; Fang SY; Lin SC; Chen JW; Chang TT
    Life Sci; 2023 Aug; 327():121863. PubMed ID: 37331504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging role of xanthine oxidase inhibition for suppression of breast cancer cell migration and metastasis associated with hypercholesterolemia.
    Oh SH; Choi SY; Choi HJ; Ryu HM; Kim YJ; Jung HY; Cho JH; Kim CD; Park SH; Kwon TH; Kim YL
    FASEB J; 2019 Jun; 33(6):7301-7314. PubMed ID: 30860872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin deficiency reduces kidney damage from hypercholesterolemia in Apolipoprotein E-deficient mice.
    Pei Z; Okura T; Nagao T; Enomoto D; Kukida M; Tanino A; Miyoshi K; Kurata M; Higaki J
    Sci Rep; 2016 Jun; 6():28882. PubMed ID: 27353458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excessive dietary lipid intake provokes an acquired form of lysosomal lipid storage disease in the kidney.
    Rampanelli E; Ochodnicky P; Vissers JP; Butter LM; Claessen N; Calcagni A; Kors L; Gethings LA; Bakker SJ; de Borst MH; Navis GJ; Liebisch G; Speijer D; van den Bergh Weerman MA; Jung B; Aten J; Steenbergen E; Schmitz G; Ballabio A; Florquin S; Aerts JM; Leemans JC
    J Pathol; 2018 Dec; 246(4):470-484. PubMed ID: 30073645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renoprotective effect of the xanthine oxidoreductase inhibitor Topiroxostat under decreased angiotensin II type 1
    Ohata K; Kamijo-Ikemori A; Sugaya T; Hibi C; Nakamura T; Murase T; Oikawa T; Hoshino S; Katayama K; Asano J; Kimura K; Shibagaki Y
    Eur J Pharmacol; 2017 Nov; 815():88-97. PubMed ID: 28888756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of topiroxostat in hyperuricemic patients with chronic kidney disease.
    Horino T; Hatakeyama Y; Ichii O; Matsumoto T; Shimamura Y; Inoue K; Terada Y; Okuhara Y
    Clin Exp Nephrol; 2018 Apr; 22(2):337-345. PubMed ID: 28752287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac hypertrophy during hypercholesterolemia and its amelioration with rosuvastatin and amlodipine.
    Kang BY; Wang W; Palade P; Sharma SG; Mehta JL
    J Cardiovasc Pharmacol; 2009 Oct; 54(4):327-34. PubMed ID: 19687748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xanthine oxidase inhibitor tungsten prevents the development of atherosclerosis in ApoE knockout mice fed a Western-type diet.
    Schröder K; Vecchione C; Jung O; Schreiber JG; Shiri-Sverdlov R; van Gorp PJ; Busse R; Brandes RP
    Free Radic Biol Med; 2006 Nov; 41(9):1353-60. PubMed ID: 17023262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of xanthine oxidase inhibitor, topiroxostat, on development of neuropathy in db/db mice.
    Takahashi K; Mizukami H; Osonoi S; Ogasawara S; Hara Y; Kudoh K; Takeuchi Y; Sasaki T; Daimon M; Yagihashi S
    Neurobiol Dis; 2021 Jul; 155():105392. PubMed ID: 34000416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changeover Trial of Febuxostat and Topiroxostat for Hyperuricemia with Cardiovascular Disease: Sub-Analysis for Chronic Kidney Disease (TROFEO CKD Trial).
    Sezai A; Unosawa S; Taoka M; Osaka S; Sekino H; Tanaka M
    Ann Thorac Cardiovasc Surg; 2020 Aug; 26(4):202-208. PubMed ID: 31748427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of genes related to oxidative/nitrosative stress in mouse hearts: effect of preconditioning and cholesterol diet.
    Kocsis GF; Csont T; Varga-Orvos Z; Puskas LG; Murlasits Z; Ferdinandy P
    Med Sci Monit; 2010 Jan; 16(1):BR32-9. PubMed ID: 20037483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis.
    Lee HS; Jeong JY; Kim BC; Kim YS; Zhang YZ; Chung HK
    Kidney Int; 1997 Apr; 51(4):1151-9. PubMed ID: 9083281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Xanthine Oxidase Protects against Sepsis-Induced Acute Kidney Injury by Ameliorating Renal Hypoxia.
    Wang TT; Du YW; Wang W; Li XN; Liu HB
    Oxid Med Cell Longev; 2022; 2022():4326695. PubMed ID: 35873795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthine Oxidase Inhibitor, Febuxostat Ameliorates the High Salt Intake-Induced Cardiac Hypertrophy and Fibrosis in Dahl Salt-Sensitive Rats.
    Namai-Takahashi A; Sakuyama A; Nakamura T; Miura T; Takahashi J; Kurosawa R; Kohzuki M; Ito O
    Am J Hypertens; 2019 Jan; 32(1):26-33. PubMed ID: 30277494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Xanthine Oxidase Activity Is Predictive of Cardiovascular Disease in Patients with Chronic Kidney Disease, Independently of Uric Acid Levels.
    Gondouin B; Jourde-Chiche N; Sallee M; Dou L; Cerini C; Loundou A; Morange S; Berland Y; Burtey S; Brunet P; Guieu R; Dussol B
    Nephron; 2015; 131(3):167-74. PubMed ID: 26426087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of xanthine oxidase inhibitor for chronic kidney disease patients with hyperuricemia.
    Matsuo H; Ishikawa E; Machida H; Mizutani Y; Tanoue A; Ohnishi T; Murata T; Okamoto S; Ogura T; Nishimura Y; Ito H; Yasutomi M; Katayama K; Nomura S; Ito M
    Clin Exp Nephrol; 2020 Apr; 24(4):307-313. PubMed ID: 31845065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of allopurinol, a xanthine oxidase inhibitor, on renal injury in hypercholesterolemia-induced hypertensive rats.
    Minami M; Ishiyama A; Takagi M; Omata M; Atarashi K
    Blood Press; 2005; 14(2):120-5. PubMed ID: 16036490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential sources of oxidative stress that induce postexercise proteinuria in rats.
    Koçer G; Sentürk UK; Kuru O; Gündüz F
    J Appl Physiol (1985); 2008 Apr; 104(4):1063-8. PubMed ID: 18258803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.